Health Condition 1: N768- Other specified inflammation of vagina and vulva
Conditions
Interventions
Intervention1: Individualised Homoeopathic medicines: Individualized homoeopathic medicines in suitable centesimal potency will be prescribed as per the principles of Homoeopathy.
Dose- 5 globules
Fre
Sponsors
Central Council for Research in Homoeopathy
Eligibility
Inclusion criteria
Inclusion criteria: 1. Married women/ Unmarried sexually active Women of age group 18-45 years presenting with complaint of abnormal vaginal discharge. 2. Women who are already taking allopathic/alternative medicines will be enrolled after 7 days washout period.
Exclusion criteria
Exclusion criteria: 1. Women with post coital bleeding or any vaginal/ cervical mass which bleeds on touch or any other sign/ symptom suspected of malignancy will be referred for standard care. 2. If any Sexually Transmitted Disease (for eg. Gonorrhea or Chlamydia) is found on culture, the patient will be excluded and advised to take Standard allopathic treatment along with partner 3. Pregnant and lactating women 4. Women with physiological leucorrhea 5. Women with uncontrolled or life threatening systemic illnesses 6. Unwilling to participate in the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. ORIDL 2. VS Questionnaire 3. Vaginal swab culture will be done at baseline, 1st and 3rd month. If needed, also at 6 monthsTimepoint: 1. ORIDL at every follow-up 2. VS Questionnaire at every follow up 3. Vaginal swab culture will be done at baseline, 1st and 3rd month. If needed, also at 6 months. | — |
Secondary
| Measure | Time frame |
|---|---|
| WHOQOL-BREFTimepoint: at baseline, 1st, 3rd & 6th month | — |
Countries
India
Contacts
Public ContactDr Sonia Raizada
Central Council for Research in Homoeopathy
Outcome results
None listed